AVANIR PHARMACEUTICALS (AVN.R) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Mar 1, 2006 involved a transaction of 750 shares valued at $7.5K.
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 1, 2006 | E. Berg James | Executive | Option Exercise | 750 | $10.00 | $7.5K | |
| Mar 1, 2006 | E. Berg James | Executive | Option Exercise | 2,500 | $5.88 | $14.7K |
No significant insider buying has been recorded for AVN.R in the recent period.
No significant insider selling has been recorded for AVN.R in the recent period.
Based on recent SEC filings, insider sentiment for AVN.R is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at AVANIR PHARMACEUTICALS (AVN.R) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading AVN.R stock, having executed 2 transactions in the past 90 days. The most active insider is James E. Berg (Executive), who has made 2 transactions totaling $22.2K.
Get notified when executives and directors at AVN.R file new Form 4 transactions
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 2 | $22.2K | 100.0% |
Insider activity at AVANIR PHARMACEUTICALS shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.1 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, James E. Berg, has transacted $22.2K during this period.